AR/101

DRUG2 trials

Sponsors

Arava Bio Tech Ltd.

Conditions

Other Ulcers Wounds and Skin ProblemsWoundsWounds and Injuries

Phase 2

Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

Arava Bio Tech Ltd.Wounds and Injuries

Start: 2015-11-30End: 2017-06-30Target: 18Updated: 2016-07-19

Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds

Arava Bio Tech Ltd.Other Ulcers Wounds and Skin Problems, Wounds

Start: 2016-08-31End: 2017-12-31Target: 60Updated: 2016-07-20